Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Eye Neoplasms × Dermatologic × Clear all

Phase

Phase 2 5 Phase 1/2 4 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Dermatologic 1

Conditions

Melanoma 137 Keratosis, Actinic 68 Lymphoma, T-Cell, Cutaneous 33 Skin Neoplasms 24 Mycosis Fungoides 24 Lymphoma, Non-Hodgkin 22 Lymphoma, Mantle-Cell 22 Lymphoma, Large-Cell, Immunoblastic 22 Lymphoma, Large B-Cell, Diffuse 22 Lymphoma, Follicular 22 Leukemia, Lymphocytic, Chronic, B-Cell 22 Hodgkin Disease 22 Sezary Syndrome 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Lymphoma, B-Cell, Marginal Zone 21 Carcinoma, Basal Cell 21 Burkitt Lymphoma 21 Neoplasms 19 Multiple Myeloma 18 Leukemia, Hairy Cell 18 Lymphoma 17 Leukemia, Myeloid, Chronic-Phase 17 Leukemia, Myeloid, Acute 17 Leukemia, Myeloid, Accelerated Phase 17 Blast Crisis 17 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16 Neoplasm Metastasis 16 Lymphoma, Large-Cell, Anaplastic 16 Uveal Melanoma 15 Primary Myelofibrosis 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06007690 2026-03-02

CoMpass

Aura Biosciences

Phase 3 Recruiting

Uveal Melanoma, Eye Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡